Growth Metrics

Bruker (BRKR) Non-Current Deffered Revenue (2016 - 2025)

Bruker filings provide 16 years of Non-Current Deffered Revenue readings, the most recent being $109.1 million for Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue rose 9.1% to $109.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $109.1 million, a 9.1% increase, with the full-year FY2025 number at $109.1 million, up 9.1% from a year prior.
  • Non-Current Deffered Revenue hit $109.1 million in Q4 2025 for Bruker, up from $100.0 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $109.1 million in Q4 2025 to a low of $50.2 million in Q4 2021.
  • Median Non-Current Deffered Revenue over the past 5 years was $97.1 million (2024), compared with a mean of $93.3 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: soared 102.39% in 2022 and later dropped 9.94% in 2023.
  • Bruker's Non-Current Deffered Revenue stood at $50.2 million in 2021, then soared by 102.39% to $101.6 million in 2022, then decreased by 9.94% to $91.5 million in 2023, then rose by 9.29% to $100.0 million in 2024, then increased by 9.1% to $109.1 million in 2025.
  • The last three reported values for Non-Current Deffered Revenue were $109.1 million (Q4 2025), $100.0 million (Q4 2024), and $94.2 million (Q3 2024) per Business Quant data.